Showing 20 of 44 recruiting trials for “primary-biliary-cholangitis”
RecruitingNCT07449793 ↗
Biochemical Response and Clinical Outcomes in Patients With PBC
A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)
FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
👨⚕️ Ma Xiong, MD, Renji Hospital, School of Medicine, Shanghai Jiao Tong University📍 41 sites📅 Started Dec 2025View details ↗
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
RecruitingNCT07205874 ↗
Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP)
RecruitingNCT07149675 ↗
PBC Long-term Outcomes Study
Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)
EMPower Mechanisms
RELIEF: Multimodal Prehabilitation to Treat Fatigue in Patients With Primary Biliary Cholangitis
👨⚕️ Sergio Rodríguez Tajes, MD, PhD, Hospital Clinic of Barcelona📍 1 site📅 Started Feb 2025View details ↗
RecruitingNCT06675604 ↗
LEOPARD Training and Validation Data Collection Study
Colangioids to Define the Genetic Factors Involved in Atypical Primary Sclerosing Cholangitis
🏥 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico📍 1 site📅 Started Dec 2024View details ↗
A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics
RecruitingNCT06447168 ↗
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis
RecruitingNCT06297993 ↗
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
The Effects of Bromelain Supplement in Patients With Ulcerative Colitis
👨⚕️ Azita Hekmatdoost, MD, PhD, Shahid Beheshti University of Medical Sciences📍 1 site📅 Started Apr 2024View details ↗
FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis
Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC
Page 1 of 3Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →